Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 88

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 16
Chunk 88
---
)96 (67)13 ExpensesOperating expense279 352 188 Interest expense1,172 1,017 845 Total expenses1,451 1,369 1,033 Loss before income tax credits and equity in net income of subsidiaries(1,355)(1,436)(1,020)Income tax credits(477)(214)(461)Equity in net income of subsidiaries6,858 7,209 6,453 Shareholders’ net income$5,980 $5,987 $5,894 See accompanying notes.

 -146-

Elevance Health, Inc. (Parent Company Only)Statements of Comprehensive IncomeYears ended December 31(in millions)202420232022Shareholders’ net income$5,980 $5,987 $5,894 Other comprehensive income (loss), net of tax:Change in net unrealized gains/losses on investments109 1,123 (2,249)Change in non-credit component of impairment losses on investments1 — (3)Change in net unrealized gains/losses on cash flow hedges4 18 10 Change in net periodic pension and other benefit costs60 40 (70)Change in future policy benefits(2)(3)32 Foreign currency translation adjustments(6)(1)(13)Other comprehensive income (loss)166 1,177 (2,293)Total shareholders’ comprehensive income$6,146 $7,164 $3,601  See accompanying notes.

 -147-

Elevance Health, Inc. (Parent Company Only)Statements of Cash FlowsYears ended December 31(In millions)202420232022Net cash provided by operating activities$1,451 $4,113 $1,447 Investing activitiesPurchases of investments(3,240)(95)(367)Proceeds from sales, maturities, calls and redemptions of investments1,567 212 618 Repayment of note to subsidiary— — 1,500 Capitalization of subsidiaries(324)(363)(411)Changes in securities lending collateral(16)42 36 Purchases of property and equipment, net of sales(36)(55)(47)Net cash (used in) provided by investing activities(2,049)(259)1,329 Financing activitiesNet repayments of short-term borrowings— — (300)Proceeds from long